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nation plus either antidepressants (12.2%), mood-stabi-
lizers (10.5%), or both (9.9%); and antipsychotics alone
(9.6%). Greater severity, female, paranoid or schizoaf-
fective diagnoses, non-teaching and for-proﬁt hospitals
were associated with increased polypharmacy use.
Patients in public programs (Medicaid/Medicare) received
less atypical antipsychotics but more polypharmacy com-
pared to those in managed care and commercial pro-
grams. Atypical antipsychotic use increased and lithium
use decreased from 1999–2001. CONCLUSIONS:
Polypharmacy is common among hospitalized schizo-
phrenia patients. Patient and institution characteristics
inﬂuenced treatment.
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OBJECTIVES: The Clinical Care GroupsTM (CCG) soft-
ware transforms fragmented claims data into episodes of
medical conditions. The results of health care claims data
grouped by CCG indicate that many SSRI claims are not
grouped into a medically related episode. Our objective
is to describe the clinical proﬁles of SSRI users who have
ungrouped SSRI claim(s). METHODS: A random sample
(N = 1,400,000) of individuals was generated for the
study from de-identiﬁed health care claims data of a large
U.S. health plan. Individuals who had been continuously
enrolled in the health plan for the 24-month full period
between April 1, 1999 and March 30, 2001 were eligible
for the study. Those with at least 1 SSRI pharmacy claim
were selected (N = 74,739). An equal number of individ-
uals without SSRI claims were also selected. Medical and
pharmacy claims data were run through CCG version 3.1
and generated the following groups of individuals: Group
A consisting of non-SSRI users; Group B consisting of
individuals with grouped SSRI claims; and Group C con-
sisting of individuals with at least one ungrouped SSRI
claim. RESULTS: The average age in each group was: A—
36, B—42, and C—45. Prevalence of SSRI indicated dis-
orders in each group were: A—54, B—724, and C—56
(cases/1000 members). On average, individuals in group
C had 7 SSRI prescriptions whereas individuals in group
B had 9. The average health care utilization for each
group was: A—$4051, B—$9574, and C—$7920. The
average number of unique providers visited for each
group was: A—9.5, B—16.5, and C—13.4. Of the
grouped SSRI prescriptions, psychiatrists prescribed
25.0% whereas only 7.6% of the ungrouped SSRI were
prescribed by psychiatrists. CONCLUSION: Signiﬁcant
differences exist between individuals with and without
ungrouped SSRI prescriptions and may illuminate the
cause of ungrouped SSRI prescriptions.
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OBJECTIVE: This study was designed to identify predic-
tors of duration of visits among patients diagnosed 
with depression in the ambulatory medical care settings.
METHOD: Data from the 1999 National Ambulatory
Medical Care Survey (NAMCS) were used to identify
patients 10 to 75 years old with a documented diagnosis
of depression (ICD-9-CM = 296.2–296.36; 300.4 or
311). The unweighted sample size was 826. Multivariate
linear regression was used to identify the predictors.
Model variables included patients’ characteristics, treat-
ment patients received, and physicians’ characteristics.
RESULTS: Among the factors predictive of the duration
of visits, signiﬁcant factors include female patients, Med-
icaid patients, capitated payment, seen by other providers
and receipt of psychotherapy. After controlling for other
factors, physicians spend about 2.19 (95% CI: 0.03,4.35)
minutes longer with female patients during the visit than
male patients; physicians spend 8.13 (95% CI: 1.93,
14.32) minutes less with Medicaid patients compared
with patients with private insurance; Physicians spend
8.57 (95% CI: 3.96, 13.18) minutes less with patients in
a capitated visit compared to a non-capitated visit; Estab-
lished patients receive 12.30 (95% CI: 5.30, 19.31)
minutes less with the physician provider compared with
non- established patients; Patients who receive care from
other providers besides a physician such as a physician
assistant, a nurse practitioner, a nurse midwife, a R.N., a
L.P.N., a medical or nursing assistant spend 6.96 minutes
(95% CI: 3.14, 10.77) less with the physician compared
with patients who don’t receive care from other
providers. Patients who receive psychotherapy spend
15.60 (95% CI: 11.04, 20.06) minutes more than patients
who don’t receive psychotherapy. CONCLUSION: Med-
icaid, capitation payment and seen by other providers
were three signiﬁcant and negative predictors of the dura-
tion of the visit. Economic incentives may cause providers
to spend less time with patients or substitute with rela-
tive cheaper health care professionals.
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OBJECTIVES: To estimate the prevalence and trends of
antipsychotic polypharmacy, categorize polypharmacy
according to the type of antipsychotic and duration of
use, and contrast polypharmacy usage patterns with pub-
